Accueil>>D-myo-Inositol-2,4,5-triphosphate (sodium salt)

D-myo-Inositol-2,4,5-triphosphate (sodium salt) (Synonyms: Ins(2,4,5)P3 (sodium salt), 2,4,5IP3 (sodium salt))

Catalog No.GC43533

The inositol phosphates (InsP) play a critical role as small, soluble second messengers in the transmission of cellular signals.

Products are for research use only. Not for human use. We do not sell to patients.

D-myo-Inositol-2,4,5-triphosphate (sodium salt) Chemical Structure

Taille Prix Stock Qté
100μg
83,00 $US
En stock
500μg
378,00 $US
En stock
1mg
672,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The inositol phosphates (InsP) play a critical role as small, soluble second messengers in the transmission of cellular signals. The most studied InsP, D-myo-Inositol-2,4,5-triphosphate (sodium salt) (Ins(1,4,5)P3), more commonly referred to as IP3, is a second messenger produced in cells by phospholipase C (PLC)-mediated hydrolysis of phosphatidylinositol-4,5-biphosphate. Binding of Ins(1,4,5)P3 to its receptor on the endoplasmic reticulum results in opening of the calcium channels and an increase in intracellular calcium. Ins(2,4,5)P3 is a metabolically stable analog of Ins(1,4,5)P3 that is commonly used to study Ca2+ signaling pathways. Ins(2,4,5)P3 acts as a partial agonist at rat hepatic IP3 receptors, exhibiting 65% of the maximal Ca2+ response obtained with Ins(1,4,5)P3.

Avis

Review for D-myo-Inositol-2,4,5-triphosphate (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for D-myo-Inositol-2,4,5-triphosphate (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.